In light of the upcoming review of iodine and PVP-iodine, the European Commission requested the BPC to provide opinions on whether these substances negatively affect the endocrine (hormonal) systems of people or non-target organisms, such as plants and animals.
The BPC concluded that they meet the criteria for endocrine disruption and should, therefore, not be approved for the use in the EU – unless they fulfill the conditions for a derogation.